ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Boehringer Ingelheim Corporation 

P.O. Box 368
900 Ridgebury Road
Ridgefield  Connecticut  06877-0368  U.S.A.
Phone: 203-798-99-88 Fax: 203-791-62-34


SEARCH JOBS








 Company News
Volasertib, Boehringer Ingelheim Corporation´s Investigational Treatment Of Acute Myeloid Leukaemia, Is Granted "Orphan Drug Designation" In The EU And The U.S. 4/17/2014 9:42:55 AM    More...
Boehringer Ingelheim Corporation Rethinks Hepatitis Business, Braces For A Rough 2014 4/16/2014 8:09:31 AM    More...
Boehringer Ingelheim Corporation To Open Trial Data Back To 1998 In Bid To Improve Transparency Efforts 4/16/2014 6:58:19 AM    More...
American Diabetes Association Announces Research Collaboration With Boehringer Ingelheim Corporation 3/24/2014 11:07:46 AM    More...
Boehringer Ingelheim Corporation Release: New Pradaxa® Data To Be Presented During The American College of Cardiology’s 63rd Annual Scientific Session 3/24/2014 9:23:58 AM    More...
Bay Area's InterMune, Inc. (ITMN) Gains As Boehringer Ingelheim Corporation's Rival Drug Shows Mixed Results 3/24/2014 8:19:00 AM    More...
Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) Now Approved In Over 100 Countries For Stroke Prevention In Atrial Fibrillation 3/6/2014 8:44:46 AM    More...
Boehringer Ingelheim Corporation Presents Phase 3 Data For Tiotropium Across Asthma Severities 3/3/2014 9:13:27 AM    More...
Boehringer Ingelheim Corporation Release: ASTHMA: New Phase 3 Data Show Tiotropium* Respimat® Effective Across Asthma Severities 3/3/2014 8:44:56 AM    More...
Records Show Boehringer Ingelheim Corporation Did Not Disclose Pradaxa Analysis To FDA 2/26/2014 7:17:11 AM    More...
12345678910...